White Blood Cell (WBC): Diagnostic Significance and Clinical Insights

Authors:Payal Bhandari M.D., Emilia Feria, Madison Granados 

Contributors: Vivi Chador, Hailey Chin,

 

White blood cell (WBC) count

White blood cells (WBCs), or leukocytes, are a key part of the immune system. An abnormal WBC count may signal infections, toxin exposure, chronic inflammation, or a higher risk of diseases like diabetes, cancer, autoimmune disorders, and neurodegenerative conditions. The five main types of WBCs—Neutrophils, Lymphocytes, Monocytes, Eosinophils, and Basophils—each have an important role in immune defense.

Typical Adult Range

Ranges and thresholds can vary due to: 

(1) Lab-specific equipment, techniques, and chemicals, and 

(2) Patient demographics, including age, sex, and ethnicity.

 

Key Insights

 

White blood cells (WBCs), or leukocytes, are key to the immune system, protecting against infections, harmful substances, and diseases. They fight pathogens, abnormal cells, and manage inflammation, cholesterol, and reactive oxygen species (ROS).

 

The five main types of WBCs have specific roles. Neutrophils respond to bacterial and viral infections. Lymphocytes (T cells, B cells, and NK cells) are vital for adaptive immunity. Monocytes repair tissue and become macrophages or dendritic cells. Eosinophils and basophils handle allergies, inflammation, and fat regulation.

 

WBC counts reveal health issues like infections, autoimmune diseases, and cancers. Diet, exercise, stress, hydration, and toxins affect WBC levels and immune health, helping manage and prevent diseases.

 

What are White Blood Cells (WBCs)?

 

Blood contains three types of cells: red blood cells (RBCs), white blood cells (WBCs), and platelets (thrombocytes).

  • RBCs carry oxygen to tissues using hemoglobin, which gives blood its red color.

  • WBCs defend the body against pathogens like bacteria, viruses, parasites, fungi, and abnormal cells. 

  • Platelets help stop bleeding, repair injuries, and form new blood vessels.

Figure 1: Blood is divided into three parts: Blood is 55% plasma (93% water, plus salts, proteins, lipids, and glucose), 45% red blood cells (RBCs), and 1% white blood cells (WBCs) and platelets . In conditions with excessive WBCs, the buffy coat thickens, inspiring the term “leukemia,” meaning “whiteness of blood” in Greek. Unstained WBCs are colorless, but staining with hematoxylin and eosin helps distinguish them. For example, eosinophils absorb the pink eosin stain.,,,,

The WBC count test measures total leukocytes in the blood, while a WBC differential analyzes the five types: neutrophils, lymphocytes, monocytes, eosinophils, and basophils. Identifying abnormal WBCs aids early detection of infections, allergies, inflammation, blood cancers, and other diseases. It also provides key health insights and guides targeted treatments.

 

WBC Formation and Regulation 

All blood cells come from hematopoietic stem cells (HSCs) in bone marrow, mainly in flat bones like the skull, ribs, pelvis, and sternum. HSCs develop into red blood cells (RBCs), platelets, and white blood cells (WBCs). They branch into myeloid progenitor cells, which form eosinophils, basophils, monocytes, and neutrophils, and lymphoid progenitor cells, which become T cells, B cells, and natural killer cells. Most WBCs (60–70%) are made in the marrow, with the rest formed in the thymus, spleen, liver, and lymph nodes.             

Figure 2: All blood cells come from hematopoietic stem cells (hemocytoblasts) in bone marrow, mainly in flat bones like the skull, ribs, pelvis, and sternum . These stem cells differentiate into red blood cells, platelets, and white blood cells, which further develop into monocytes, lymphocytes, eosinophils, neutrophils, and basophils.

WBCs are classified into two main groups: 

  1. Granulocytes include neutrophils, eosinophils, and basophils.  Also known as polymorphonuclear leukocytes оr polys, these WBCs have granules in their cell cytoplasm and a multilobed nucleus. 

  2. Non-granulocytes include lymphocytes and monocytes. Also known as mononuclear leukocytes, these WBCs lack granules аnd hаvе non-lobular nuclei.

Mature WBCs live 13–20 days before dying or being destroyed by immune cells. They are removed by lymphatic vessels, the spleen, lymph nodes, and mucosa-associated lymphoid tissue (MALT). The MALT includes:

  • Tonsils: Located at the back of the throat, they help capture pathogens and other environmental allergens/toxins that enter through the mouth or nose.

  • Peyer’s Patches: Found in the small intestine, they monitor gut bacteria and respond to pathogens, proinflammatory proteins, atherogenic cholesterol, and reactive oxygen species (ROS; heat).

  • Appendix: Located at the junction between the small and large intestine (colon), this structure plays a critical role in immune function related to the microbiota. 

 

The bone marrow constantly produces new WBCs to fight pathogens, abnormal cells, inflammation, cholesterol, ROS, and to heal wounds.

 

WBC production is regulated by proinflammatory proteins, transcription factors, and genes controlling the circadian rhythm, nervous system, and energy use. Immune cells in the bone marrow target leukocytes producing the most proinflammatory proteins, reducing cytokines, controlling inflammation, and maintaining immune balance.

 

Clinical Significance of a High WBC Count (Leukocytosis)

 

Leukocytosis, a high WBC count above 11,000 cells/µL,  is linked to infections, tissue injury from oxidative stress, chronic inflammation, and disorders of the reticuloendothelial system, including the thymus, spleen, liver, bone marrow, and lymphoid tissues like the appendix and Peyer’s patches.

 

Leukocytosis is often caused by dehydration and atherosclerosis-induced inflammation, which reduce blood flow (vasoconstriction). In the digestive tract, vasoconstriction lowers stomach acid (HCl), disrupts gut microbiota, and causes nutrient deficiencies, leading to undigested food particles, hypoxia, and oxidative stress that impair cellular function.

 

Excess ROS damages cells, mutates genes, and reduces cell division. Damaged cells release toxins, activating WBCs, platelets, and smooth muscle cells to clear debris, form clots, and repair wounds. This inflammatory response creates scar tissue and plaques, reduces blood flow, raises blood pressure, and increases blood cell demand.

 

Figure 3: Healthy microbiota in the small and large intestines play a crucial role in maintaining overall digestive health and metabolic balance. A balanced microbiota aids digestion, nutrient absorption, and waste excretion. Dysbiosis, a loss of healthy bacteria, disrupts metabolism and increases harmful pathogens in the gut, affecting immune and harmful responses.

 

Figure 4: Atherosclerosis causes fat buildup, scar tissue thickening (hyperplasia tunica intima), and clot formation by platelets to repair vessel damage. It restricts arterial blood flow, raises blood pressure, redirects venous flow, and leads to blood backup in organs like the heart, pancreas, liver, and lower extremities. Chronic inflammation from leukocytosis can damage organ structure and reduce function .

A 2017 American Journal of Epidemiology study linked rising WBC counts to worsening atherosclerosis and shorter lifespans. Persistent tissue injury overwhelms the reticuloendothelial system (liver, spleen, bone marrow, thymus, lymph nodes) and organs like the small intestine and kidneys, which clear toxic byproducts. Chronic inflammation reduces blood flow, damages microbiota, and reactivates dormant viruses 14 . 

 

Viruses, 100 times smaller than bacteria, carry RNA or DNA in a protein, fat, or sugar coat and replicate inside host cells. Dormant for months or years, they activate under stress, releasing toxins like hemolysin that damage cell membranes, destroy red blood cells, and release iron for viral replication   . 

 

                    

Figure 5: A virus infecting a cell. Viruses infect host cells by attaching to specific receptors and injecting their genetic material or entering through endocytosis. Inside, they hijack the cell’s functions to replicate and produce new viral particles, which then infect neighboring cells.

WBCs fight viral infections to prevent illness, but a weakened immune system allows viruses to spread through bodily fluids, pregnancy, childbirth, direct contact, contaminated food, water, insects, animals, or humans 6. Viruses can damage infected organs, causing cognitive issues, mood disorders, brain atrophy, and other symptoms . A 1994 study found 78% of people with chronic fatigue syndrome showed markers of chronic viral infections like Epstein-Barr, with nearly 50% having elevated antibodies to HHV and HSV, often found in elderly brains.  

 

Recent studies estimate that 1 in 10 cancers stems from chronic atherosclerosis-induced inflammation and dysbiosis, which promote chronic infections (e.g., HIV, HSV, EBV, HHV, tuberculosis), cancer cell growth, and organ depletion. 

 

Figure 6: Chronic inflammation increases reactive oxygen species (ROS) and proinflammatory proteins, triggering leukocytosis and platelet activation. This leads to clot formation, scar tissue (fibrosis), restricted blood flow, and higher blood pressure. 

Figure 7: Excess oxidized cholesterol, proinflammatory proteins, and ROS cause tissue damage, gene mutations, and reduced cell division, while low nitric oxide disrupts blood vessel function. Injured cells attract oxidized cholesterol and neutrophils, which attempt to stabilize the damage but shield tumor cells. Tumor cells bind to arterial walls, activate platelets, and promote clotting and new blood vessels (angiogenesis), while suppressing natural killer (NK) cells. Proinflammatory proteins further support cancer cell growth and spread in blood vessels.

Clinical Significance of a Low WBC Count (Leukopenia)

 

Leukopenia, a low WBC count, signals a compromised reticuloendothelial system (spleen, liver, lymph nodes, bone marrow) struggling to function. The spleen filters blood, produces WBCs, and removes waste. Leukopenia is more common in the elderly due to reduced WBC production and chronic conditions. High-risk groups include those with nutritional deficiencies (e.g., vitamin B12 or folate), chronic infections, or those on immunosuppressive therapies. Without WBCs, inflammation can shut down organ function . 

Leukopenia also reflects overactivated and dysregulated WBCs, which focus on clearing debris and repairing tissue instead of targeting pathogens or abnormal cells. Proinflammatory proteins released during inflammation may cause lymphocytes to attack healthy tissues, increasing the risk of autoimmune diseases like diabetes, NAFLD, rheumatoid arthritis, lupus, and inflammatory bowel diseases, leading to organ damage   . 

 

Autoimmune diseases affect 3–5% of the population, with rising prevalence. Type 1 diabetes (T1DM) affects 15 per 100,000 in the U.S. and 9.5% globally. In 2021, 8.4 million people had T1DM: 18% under 20, 64% aged 20–59, and 19% over 60. That year, 500,000 new cases were diagnosed, with a median onset age of 29. One-fifth (1.8 million) of T1DM cases occur in low- and lower-middle-income countries .

Type 2 Diabetes and Liver Diseases 

In 2015, 1 in 11 adults worldwide (415 million people) aged 20–79 had diabetes, with over 90% having type 2 diabetes (T2DM). Obese individuals with T2DM show higher WBC activation than lean individuals, indicated by elevated neutrophil elastase (NE) and myeloperoxidase (MPO) levels, which reduce blood flow and worsen dysbiosis. Gut microbiota supports digestion, nutrient absorption, and waste elimination, but increased WBC and neutrophil counts from undigested food particles trigger inflammation, releasing ROS and proinflammatory proteins. This damages cells, mutates genes, disrupts metabolism, and reduces healthy cell growth, leading to chronic inflammation linked to obesity, NAFLD, diabetes, and atherosclerosis. 

 

55% of individuals with type 2 diabetes (T2DM) also have non-alcoholic fatty liver disease (NAFLD), which includes conditions like steatosis and non-alcoholic steatohepatitis (NASH). These are characterized by chronic inflammation, fibrosis, and liver cell death 33. WBC infiltration in the liver worsens NASH and contributes to leukopenia. NAFLD is the leading cause of chronic liver disease-related morbidity and mortality worldwide and is closely linked to atherosclerosis, the leading global cause of death .

Figure 8: The liver metabolizes cholesterol and proteins, synthesizes new proteins and amino acids, and detoxifies cellular waste. Liver dysfunction leads to excess proinflammatory proteins and reactive oxygen species, triggering inflammation and overactivating WBCs like neutrophils. This redirects nutrients and oxygen from essential organs to toxin clearance, disrupting normal functions. Chronic inflammation damages the liver, causing steatohepatitis, fibrosis, or cirrhosis, depending on disease severity.

 

Type 1 Diabetes 

Type 1 diabetes mellitus (T1DM) is a chronic autoimmune disease where reactive oxygen species (ROS) destroy pancreatic cells, reducing hormones like insulin, glucagon, and leptin. Insulin deficiency blocks glucose uptake into cells, raising blood glucose and ROS levels 33. The liver increases glucose production, stores fat, and breaks down muscle while reducing fat metabolism, leading to excess undigested proteins, fats, and glucose in the bloodstream. This impairs red blood cells’ oxygen delivery (hypoxia), disrupting cell function and releasing toxic byproducts. Chronic inflammation over stimulates the reticuloendothelial system, causing leukocytopenia . Newly diagnosed or high-risk T1DM individuals often show increased WBC infiltration into damaged organs, a key marker of pancreatic beta-cell destruction . 

 

Inflammatory Bowel Diseases and Food Allergies

Inflammatory bowel diseases (IBD), including Crohn’s disease, ulcerative colitis (UC), celiac disease, and food allergies, are autoimmune disorders affecting the digestive tract . UC is limited to the colon, while Crohn’s and other conditions can impact any part of the tract. Celiac disease, triggered by gluten, mainly affects the small intestine. The incidence of IBD is 10.9 per 100,000 person-years, peaking in the 30s and stabilizing until later life. As of 2020, 721 per 100,000 (about 2.39 million people) in the U.S. were diagnosed with IBD, with higher rates among Caucasians and those of Mexican descent compared to Black, Asian, and other Hispanic populations.

 

IBD results from environmental factors that increase undigested food particles in the gut, triggering inflammation 14 .   Stress—emotional, physical, or physiological—overactivates the HPA axis and sympathetic nervous system, reducing gut blood flow and healthy gut bacteria. This imbalance allows overgrowth of harmful microorganisms like viruses, fungi, parasites, and bacteria. Dysbiosis in the small intestine, known as SIBO, disrupts gut function and is a key feature of IBD. Excess WBCs infiltrate the intestine to contain undigested particles, preventing gut lining damage, blood vessel penetration, and bloodstream leaks . The immune response to “leaky gut” protects barriers but causes chronic inflammation, damaging cells, tissues, and organs, disrupting normal body functions.

Chronic Obstructive Lung Diseases

In 2021, 14.2 million U.S. adults (6.5%) were diagnosed with chronic lung diseases like COPD, a rate unchanged since 2011 . COPD is more common in smaller towns and rural areas due to higher smoking rates, fewer quitters, and an aging population. About 25% of COPD cases (3.8 million) occur in non-smokers, a consistent trend. Rural areas also face challenges like poverty, limited social support, and fewer job opportunities, which may contribute to higher COPD rates.

 

Patients with COPD experience increased lung WBC infiltration due to hypoxia, which accelerates red blood cell destruction and vascular inflammation. WBCs clear tissue debris and aid wound healing. Lung trauma impairs alveoli from delivering oxygen to tissues, while megakaryocytes (MKs), usually in bone marrow, migrate to oxygen-deficient lung areas 33. Megakaryocytes (MK), traditionally thought to reside only in the bone marrow, escape into the venous blood, travel to the lungs, and hide in areas with reduced or absent oxygen . Chronic stress converts MKs into platelets, with the lungs producing up to 10 million activated platelets per hour, contributing to atherosclerosis-related diseases and autoimmune disorders 47. 

 

Figure 9: Low blood oxygen triggers increased red blood cell production, causing megakaryocytes (MKs) to escape the bone marrow and travel to the lungs. When oxygen levels rise, lung MKs convert to activated platelets, which are quickly destroyed. Chronic inflammation accelerates platelet degradation, reducing liver production of thrombopoietin and suppressing platelet production in the bone marrow.

Conclusion

The WBC count is a key measure of immune health. Different WBC types play vital roles in diagnosing and managing various conditions. Abnormal WBC counts can indicate inflammation linked to dehydration, nutrient deficiencies, energy imbalances, and hormonal issues. High WBC counts (leukocytosis) may increase the risk of vascular injury, excessive ROS production, high blood pressure, and impaired organ function. Low WBC counts (leukopenia) are associated with chronic inflammation, higher risks of autoimmune disorders, pathogen activation, cancer cell growth, and organ depletion.

Managing abnormal WBC counts requires a holistic approach, including lifestyle changes, a healthy diet, reduced drug use, regular exercise, and proper hydration. These interventions can often correct abnormalities without the need for medications, which may disrupt WBC production. Poor nutrition, sleep disturbances, and high stress levels affect blood flow, gut health, digestion, nutrient absorption, energy regulation, and hormonal balance. A multidisciplinary strategy is essential to manage WBC counts, lower health risks, and improve overall well-being.

 

Source References and Supplemental Research

  1. Young B, Lowe jo, Stevens A, Heath JW (2006). Wheater’s Functional Histology (5th ed.). Elsevier Limited. ISBN 978-0-443-06850-8.

  2. Cottler-Fox, Michele; Montgomery, Matthew; Theus, John (2009-01-01), Treleaven, Jennifer; Barrett, A John (eds.), “CHAPTER 24 – Collection and processing of marrow and blood hematopoietic stem cells”, Hematopoietic Stem Cell Transplantation in Clinical Practice, Edinburgh: Churchill Livingstone, pp. 249–256.

  3. Mescher, Anthony L. (2018). “Blood”. Junqueira’s Basic Histology: Text and Atlas (15 ed.). McGraw-Hill Education. p. 237.

  4. Marieb, Elaine N. (2007). Human Anatomy & Physiology (Seventh ed.). San Francisco: Pearson Benjamin Cummings.

  5. Mychaleckyj, Josyf C; Farber, Emily A; Chmielewski, Jessica; Artale, Jamie; Light, Laney S; Bowden, Donald W; Hou, Xuanlin; Marcovina, Santica M (10 June 2011). “Buffy coat specimens remain viable as a DNA source for highly multiplexed genome-wide genetic tests after long-term storage”. Journal of Translational Medicine. 9: 91.

  6. Fabre, Anne-Lise; Luis, Aurélie; Colotte, Marthe; Tuffet, Sophie; Bonnet, Jacques (30 November 2017). “High DNA stability in white blood cells and buffy coat lysates stored at ambient temperature under anoxic and anhydrous atmosphere”. PLOS ONE. 12 (11): e0188547.

  7. Grinenko T, Eugster A, Thielecke L, et al. Hematopoietic stem cells can differentiate into restricted myeloid progenitors before cell division in mice. Nat Commun. 2018;9(1):1898. Published 2018 May 15. doi:10.1038/s41467-018-04188-7 [PMC Full Text] [PubMed] [Crosslink]

  8. Grinenko T, Eugster A, Thielecke L, et al. Hematopoietic stem cells can differentiate into restricted myeloid progenitors before cell division in mice. Nat Commun. 2018;9(1):1898. Published 2018 May 15. doi:10.1038/s41467-018-04188-7 [PMC Full Text] [PubMed] [Crosslink]

  9. Jerigova V, Zeman M, Okuliarova M. Circadian Disruption and Consequences on Innate Immunity and Inflammatory Response. International Journal of Molecular Sciences. 2022; 23(22):13722. https://doi.org/10.3390/ijms232213722. [MDPI]

  10. Druzd, D., de Juan, A. & Scheiermann, C. Circadian rhythms in leukocyte trafficking. Semin Immunopathol 36, 149–162 (2014). https://doi.org/10.1007/s00281-013-0414-4. [SpringerLink]

  11. Tahir N. Neutrophilia. [StatPearls]. April 27, 2023. Accessed July 9, 2024. https://www.ncbi.nlm.nih.gov/books/NBK570571/.

  12. What Is Gut Dysbiosis? Cleveland Clinic. [Cleveland Clinic]

  13. Nordestgaard, B. G., & Varbo, A. (2014). Triglycerides and cardiovascular disease. The Lancet, 384(9943), 626–635. https://doi.org/10.1016/s0140-6736(14)61177-6 [Science Direct] [Scopus] [Google Scholar]

  14. Varbo, A., Benn, M., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2013). Elevated remnant cholesterol causes both Low-Grade inflammation and ischemic heart disease, whereas elevated Low-Density lipoprotein cholesterol causes ischemic heart disease without inflammation. Circulation, 128(12), 1298–1309. https://doi.org/10.1161/circulationaha.113.003008 [Scopus] [Google Scholar]

  15. Silvestre-Roig C, Braster Q, Ortega-Gomez A, Soehnlein O. Neutrophils as regulators of cardiovascular inflammation. Nat Rev Cardiol. 2020;17:327–40. [PubMed] [Crosslink].

  16. Soehnlein O, Steffens S, Hidalgo A, Weber C. Neutrophils as protagonists and targets in chronic inflammation. Nat Rev Immunol. 2017;17:248–61. [PubMed] [Crosslink].

  17. Soehnlein O, Libby P. Targeting inflammation in atherosclerosis — from experimental insights to the clinic. Nat Rev Drug Discov. 2021;20:589–610. [PubMed].

  18. Kabat GC, Kim MY, Manson JE, et al. White Blood Cell Count and Total and Cause-Specific Mortality in the Women’s Health Initiative. Am J Epidemiol. 2017;186(1):63-72. doi:10.1093/aje/kww226. [PubMed]

  19. [1]Alberts B, Johnson A, Lewis J, et al. Molecular Biology of the Cell. 4th edition. New York: Garland Science; 2002. Cell Biology of Infection. https://www.ncbi.nlm.nih.gov/books/NBK26833/

  20. [1]Alberts B, Johnson A, Lewis J, et al. Molecular Biology of the Cell. 4th edition. New York: Garland Science; 2002. Cell Biology of Infection. https://www.ncbi.nlm.nih.gov/books/NBK26833/

  21. Vandenesch, F, Lina G, Henry T. Staphylococcus aureus hemolysins, bi-component leukocidins, and cytolytic peptides: a redundant arsenal of membrane-damaging virulence factors? Front. Cell. Infect. Microbiol., 15 February 2012. Sec. Bacteria and Host. Volume 2 – 2012. https://doi.org/10.3389/fcimb.2012.00012. [Frontiers]

  22. Islam MM, Takeyama N. Role of Neutrophil Extracellular Traps in Health and Disease Pathophysiology: Recent Insights and Advances. International Journal of Molecular Sciences. 2023; 24(21):15805. https://doi.org/10.3390/ijms242115805. [MDPI]

  23. Li, J., Zhang, K., Zhang, y. et al. Neutrophils in COVID-19: recent insights and advances. Virol J 20, 169 (2023). https://doi.org/10.1186/s12985-023-02116-w. [BioMed Central]

  24. Pyzik A, Grywalska E, Matyjaszek-Matuszek B, et al. Does the Epstein-Barr Virus Play a Role in the Pathogenesis of Graves’ Disease?. Int J Mol Sci. 2019;20(13):3145. Published 2019 Jun 27. doi:10.3390/ijms20133145 [Pubmed] [MDPI] [PMC]

  25. Hilgers A, Frank J. Chronic Fatigue Syndrome: immune dysfunction, role of pathogens and toxic agents and neurological and cardiac changes. Wien Med Wochenschr. 1994;144(16):399-406. [Pubmed]

  26. Wang Y, Ding L, Zhu Q, Shu M, Cai Q. Common Infections May Lead to Alzheimer’s Disease. Virol Sin. 2018;33(5):456-458. doi:10.1007/s12250-018-0049-7 [Pubmed] [Springer]

  27. Alizon S, Bravo IG, Farrell PJ, Roberts S. Towards a multi-level and a multi-disciplinary approach to DNA oncovirus virulence. Philos Trans R Soc Lond B Biol Sci. 2019;374(1773):20190041. doi:10.1098/rstb.2019.0041 [Pubmed] [The Royal Society] [PMC]

  28. Landolfi R, Di Gennaro L. Pathophysiology of thrombosis in myeloproliferative neoplasms. Haematologica. 2011;96(2):183-186. doi:10.3324/haematol.2010.038299 [PubMed] [PMC Full Text] [Crosslink]

  29. Ing VW. The etiology and management of leukopenia. Can Fam Physician. 1984;30:1835-1839.[PubMed]

  30. Landolfi R, Di Gennaro L. Pathophysiology of thrombosis in myeloproliferative neoplasms. Haematologica. 2011;96(2):183-186. doi:https://doi.org/10.3324/haematol.2010.038299 [Haematologica]

  31. Zheng Y, Ley SH, Hu FB. Global etiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14:88–98. [PubMed] [Crosslink].

  32. Poznyak A, Grechko AV, Poggio P, Myasoedova VA, Alfieri V, Orekhov AN. The diabetes mellitus–atherosclerosis connection: the role of lipid and glucose metabolism and chronic inflammation. Int J Mol Sci. 2020;21:1835. [PMC Full Text] [Crosslink].

  33. Wang L, Wang FS, Gershwin ME. Human autoimmune diseases: a comprehensive update. J Intern Med. 2015;278:369–95. [PubMed] [Crosslink].

  34. Mobasseri M, Shirmohammadi M, Amiri T, Vahed N, Hosseini Fard H, Ghojazadeh M. Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis. Health Promot Perspect. 2020;10(2):98-115. Published 2020 Mar 30. doi:10.34172/hpp.2020.18 [PubMed] [PMC Full Text] [Crosslink]

  35. Gregory GA, Robinson TIG, Linklater SE, et al. Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study [published correction appears in Lancet Diabetes Endocrinol. 2022 Nov;10(11):e11. doi: 10.1016/S2213-8587(22)00280-7]. Lancet Diabetes Endocrinol. 2022;10(10):741-760. doi:10.1016/S2213-8587(22)00218-2 [PubMed] [Crosslink]

  36. Herrero-Cervera, A., Soehnlein, O. & Kenne, E. Neutrophils in chronic inflammatory diseases. Cell Mol Immunol 19, 177–191 (2022). https://doi.org/10.1038/s41423-021-00832-3. [Nature]

  37. Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24:908–22. [PubMed] [PMC Full Text] [Crosslink].

  38. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update From the GBD 2019 study. J Am Coll Cardiol. 2020;76:2982–3021. [PubMed] [PMC Full Text] [Crosslink].

  39. Qin J, Fu S, Speake C, Greenbaum CJ, Odegard JM. NETosis-associated serum biomarkers are reduced in type 1 diabetes in association with neutrophil count. Clin Exp Immunol. 2016;184:318–22. [PubMed] [PMC Full Text] [Crosslink].

  40. Dufort MJ, Greenbaum CJ, Speake C, Linsley PS. Cell type-specific immune phenotypes predict loss of insulin secretion in new-onset type 1 diabetes. JCI insight. 2019;4:e125556. [PMC Full Text] [Crosslink].

  41. Harsunen M, Puff R, D’Orlando O, Giannopoulou E, Lachmann L, Beyerlein A, et al. Reduced blood leukocyte and neutrophil numbers in the pathogenesis of type 1 diabetes. Horm Metab Res. 2013;45:467–70. [PubMed] [Crosslink].

  42. McDowell C, Farooq U, Haseeb M. Inflammatory Bowel Disease. [Updated 2023 Aug 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470312/

  43. Lewis JD, Parlett LE, Jonsson Funk ML, et al. Incidence, Prevalence, and Racial and Ethnic Distribution of Inflammatory Bowel Disease in the United States. Gastroenterology. 2023;165(5):1197-1205.e2. doi:10.1053/j.gastro.2023.07.003 [PubMed] [Crosslink]

  44. Zhang YZ, Li YY. Inflammatory bowel disease: pathogenesis. World J Gastroenterol 2014;20:91–9. [PubMed] [PMC Full Text] [Crosslink].

  45. Nikolakis D, de Voogd FAE, Pruijt MJ, Grootjans J, van de Sande MG, D’Haens GR. The Role of the Lymphatic System in the Pathogenesis and Treatment of Inflammatory Bowel Disease. International Journal of Molecular Sciences. 2022; 23(3):1854. https://doi.org/10.3390/ijms23031854. [MDPI]

  46. Liu Y, Carlson SA, Watson KB, Xu F, Greenlund KJ. Trends in the Prevalence of Chronic Obstructive Pulmonary Disease Among Adults Aged ≥18 Years — United States, 2011–2021. MMWR Morb Mortal Wkly Rep 2023;72:1250–1256. DOI: http://dx.doi.org/10.15585/mmwr.mm7246a1.

  47. Zhao. Platelet generation from circulating megakaryocytes is triggered in the lung vasculature. BioRXiv (2021) bioRxiv 2021.11.01.466743. doi: 10.21203/rs.3.rs-690639/v1 [BioRXiv Full Text] [Crosslink]

  48. Gelon L, Fromont L, Lefrançais E. Occurrence and role of lung megakaryocytes in infection and inflammation. Frontiers in Immunology. 2022;13. doi:10.3389/fimmu.2022.1029223 [PubMed] [PMC Full Text] [Crosslink]

  49. Yen Jean MC, Hsu CC, Hung WC, et al. Association between lifestyle and hematological parameters: A study of Chinese male steelworkers. J Clin Lab Anal. 2019;33(7):e22946. doi:10.1002/jcla.22946 [PubMed] [PMC Full Text] [Crosslink]

  50. Wirth MD, Sevoyan M, Hofseth L, Shivappa N, Hurley TG, Hébert JR. The Dietary Inflammatory Index is associated with elevated white blood cell counts in the National Health and Nutrition Examination Survey. Brain Behav Immun. 2018;69:296-303. doi:10.1016/j.bbi.2017.12.003 [PubMed] [PMC Full Text] [Crosslink]

  51. Gibson C, Berliner N. How we evaluate and treat neutropenia in adults. Blood. 2014;124(8):1251-1258. doi:10.1182/blood-2014-02-482612 [Crosslink]

  52. 1. Cedars-Sinai Staff. Are animal proteins better for you than plant proteins? Cedars Sinai. January 16, 2019. Accessed September 2, 2024. [Website]

  53. Koenig G, Seneff S. Gamma-glutamyltransferase: A predictive biomarker of cellular antioxidant inadequacy and disease risk. Dis Markers. 2015:2015:818570. PMID: 26543300. doi: 10.1155/2015/818570. [PubMed] [Wiley] [PubMed]

  54. De Chiara, F., Checcllo, C. U., & Azcón, J. R. (2019). High protein diet and metabolic plasticity in Non-Alcoholic Fatty liver Disease: Myths and Truths. Nutrients, 11(12), 2985. https://doi.org/10.3390/nu11122985 [PubMed]

  55. Guoyao Wu; Yun-Zhong Fang; Sheng Yang; Joanne R. Lupton; Nancy D. Turner (2004). “Glutathione Metabolism and its Implications for Health”. Journal of Nutrition. 134 (3): 489–492. doi:10.1093/jn/134.3.489. PMID 14988435 [PubMed] [Crosslink]

  56. Ho, P.I.; Ortiz, D.; Rogers, E.; Shea, T.B. Multiple aspects of homocysteine neurotoxicity: Glutamate excitotoxicity, kinase hyperactivation and DNA damage. J. Neurosci. Res. 2002, 70, 694–702. [Google Scholar] [CrossRef] [PubMed]

  57. Menni C, Louca P, Berry SE, et al. High intake of vegetables is linked to lower white blood cell profile and the effect is mediated by the gut microbiome. BMC Med. 2021;19(1):37. Published 2021 Feb 11. doi:10.1186/s12916-021-01913-w [PubMed] [PMC Full Text] [Crosslink]

  58. Hernáez Á, Lassale C, Castro-Barquero S, Babio N, Ros E, Castañer O, Tresserra-Rimbau A, Pintó X, Martínez-González MÁ, Corella D, et al. Mediterranean Diet and White Blood Cell Count—A Randomized Controlled Trial. Foods. 2021; 10(6):1268. https://doi.org/10.3390/foods10061268. [MDPI]

  59. Moll S, Varga EA. Homocysteine and MTHFR Mutations. Circulation. 2015;132(1). doi:https://doi.org/10.1161/circulationaha.114.013311 [AHA Journals] [Crosslink]

  60. Esse, R.; Barroso, M.; Almeida, I.; Castro, R. The contribution of homocysteine metabolism disruption to endothelial dysfunction: State-of-the-art. Int. J. Mol. Sci. 2019, 20, 867. [Google Scholar] [CrossRef] [Green Version].

  61. Kruman, I.I.; Culmsee, C.; Chan, S.L.; Kruman, Y.; Guo, Z.; Penix, L.; Mattson, M.P. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J. Neurosci. 2000, 20, 6920–6926. [PubMed]

  62. Ho, P.I.; Ashline, D.; Dhitavat, S.; Ortiz, D.; Collins, S.C.; Shea, T.B.; Rogers, E. Folate deprivation induces neurodegeneration: Roles of oxidative stress and increased homocysteine. Neurobiol. Dis. 2003, 14, 32–42. [PubMed]

  63. Piskin E, Cianciosi D,  Gulec S, Tomas M, Capanoglu E. Iron Absorption: Factors, Limitations, and Improvement Methods. ACS Omega. 2022 Jun 21; 7(24): 20441–20456. doi: 10.1021/acsomega.2c01833 [PMC] [Crosslink]

  64. Boldt D. H. New Perspectives on Iron: An Introduction. Am. J. Med. Sci. 1999, 318 (4), 207. 10.1097/00000441-199910000-00001. [PubMed]

  65. Smirnoff N. Ascorbic Acid Metabolism and Functions: A Comparison of Plants and Mammals. Free Radic. Biol. Med. 2018, 122, 116–129. 10.1016/j.freeradbiomed.2018.03.033. [PubMed]

  66. Benkhedda K.; L’abbé M. R.; Cockell K. A. Effect of Calcium on Iron Absorption in Women with Marginal Iron Status. Br. J. Nutr. 2010, 103 (5), 742–748. 10.1017/S0007114509992418. [PubMed] [Cambridge Core]

  67. Ziegler E.E. Consumption of cow’s milk as a cause of iron deficiency in infants and toddlers. Nutr. Rev. 2011;69:37–42. doi: 10.1111/j.1753-4887.2011.00431.x. [PubMed] [Oxford Academic]

  68. Cory H, Passarelli S, Szeto J, Tamez M, Mattei J. The Role of Polyphenols in Human Health and Food Systems: A Mini-Review. Front Nutr. 2018;5:87. Published 2018 Sep 21. doi:10.3389/fnut.2018.00087 [PubMed]

  69. [1]Zhang H, Tsao R. Dietary polyphenols, oxidative stress and antioxidant and anti-inflammatory effects. Curr Opin Food Sci. (2016) 8:33–42. 10.1016/j.cofs.2016.02.002 [CrossRef] [Google Scholar]

  70. 1. Sandberg A-S, Scheers N. Phytic Acid: Properties, Uses, and Determinations. In: ; :365-368. Accessed September 2, 2024. [ScienceDirect]

  71. Hart J. J.; Tako E.; Kochian L. V.; Glahn R. P. Identification of Black Bean (Phaseolus Vulgaris L.) Polyphenols That Inhibit and Promote Iron Uptake by Caco-2 Cells. J. Agric. Food Chem. 2015, 63 (25), 5950–5956. 10.1021/acs.jafc.5b00531. [PubMed]

  72. Naghedi-Baghdar, H., Nematy, M., Kooshyar, M. M., Taghipour, A., Sajadi Tabassi, S. A., Shokri, S., Javan, R., & Nazari, S. M. (2018). Effect of a functional food (vegetable soup) on blood rheology in patients with polycythemia. Avicenna journal of phytomedicine, 8(5), 389–398. [PubMed]

  73. [1]Watso, J. C., & Farquhar, W. B. (2019). Hydration Status and Cardiovascular Function. Nutrients, 11(8), 1866. https://doi.org/10.3390/nu11081866 [PubMed]

  74. Ramsay DJ. Homeostatic control of water balance. In: Arnaud MJ, editor. Hydration Throughout Life. Montrouge: John Libbey Eurotext; 1998. pp. 9–18.

  75. Bunn HF. Hemoglobin I. Structure and function. In: Beck WS, Hematology. Cambridge, MA: MIT Press, 1981;129.

  76. [1]Kennedy M. How much water you’re actually supposed to drink each day – and why 8 cups isn’t right for everyone. Business Insider. December 14, 2021. [Website]

  77. Pałka T, Koteja PM, Tota Ł, et al. The Influence of Various Hydration Strategies (Isotonic, Water, and No Hydration) on Hematological Indices, Plasma Volume, and Lactate Concentration in Young Men during Prolonged Cycling in Elevated Ambient Temperatures. Biology (Basel). 2023;12(5):687. Published 2023 May 7. doi:10.3390/biology12050687 [PubMed] [PMC Full Text] [Crosslink]

  78. Ballard H. S. (1997). The hematological complications of alcoholism. Alcohol health and research world, 21(1), 42–52. [PubMed]

  79. Bradley CS, Erickson BA, Messersmith EE, et al. Evidence of the Impact of Diet, Fluid Intake, Caffeine, Alcohol and Tobacco on Lower Urinary Tract Symptoms: A Systematic Review. J Urol. 2017;198(5):1010-1020. doi:10.1016/j.juro.2017.04.097 [PubMed] [PMC Full Text] [Full Text]

  80. Polhuis KCMM, Wijnen AHC, Sierksma A, Calame W, Tieland M. The Diuretic Action of Weak and Strong Alcoholic Beverages in Elderly Men: A Randomized Diet-Controlled Crossover Trial. Nutrients. 2017;9(7):660. Published 2017 Jun 28. doi:10.3390/nu9070660 [PubMed]

  81. Chung PS, Tsai KZ, Lin YP, Lin YK, Lin GM. Association between Leukocyte Counts and Physical Fitness in Male Military Members: The CHIEF Study. Sci Rep. 2020;10(1):6082. Published 2020 Apr 8. doi:10.1038/s41598-020-63147-9 [PubMed] [PMC Full Text] [Crosslink]

  82. Johannsen NM, Swift DL, Johnson WD, et al. Effect of different doses of aerobic exercise on total white blood cell (WBC) and WBC subfraction number in postmenopausal women: results from DREW. PLoS One. 2012;7(2):e31319. doi:10.1371/journal.pone.0031319 [PubMed] [PMC Full Text] [Crosslink]

  83. El-Sayed M. S. (1998). Effects of exercise and training on blood rheology. Sports medicine (Auckland, N.Z.), 26(5), 281–292. https://doi.org/10.2165/00007256-199826050-00001 [PubMed] [Springer]

  84. Kilic-Toprak, E., Ardic, F., Erken, G., Unver-Kocak, F., Kucukatay, V., & Bor-Kucukatay, M. (2012). Hemorheological responses to progressive resistance exercise training in healthy young males. Medical science monitor : international medical journal of experimental and clinical research, 18(6), CR351–CR360. https://doi.org/10.12659/msm.882878 [PubMed] [ISI] [PubMed]

  85. Kamal A, Malik RN. Hematological Evidence of Occupational Exposure to Chemicals and Other Factors among Auto-Repair Workers in Rawalpindi, Pakistan. Osong Public Health Res Perspect. 2012;3(4):229-238. doi:10.1016/j.phrp.2012.10.003 [PubMed]

  86. Premont RT, Reynolds JD, Zhang R, Stamler JS. Role of Nitric Oxide Carried by Hemoglobin in Cardiovascular Physiology: Developments on a Three-Gas Respiratory Cycle. Circ Res. 2020;126(1):129-158. doi:10.1161/CIRCRESAHA.119.315626 [PubMed] [PMC Full Text] [Circulation Research]

  87. Pedersen KM, Çolak Y, Ellervik C, Hasselbalch HC, Bojesen SE, Nordestgaard BG. Smoking and Increased White and Red Blood Cells. Arterioscler Thromb Vasc Biol. 2019;39(5):965-977. doi:10.1161/ATVBAHA.118.312338 [PubMed] [Crosslink]

  88. Carel RS, Eviatar J. Factors affecting leukocyte count in healthy adults. Prev Med. 1985;14(5):607-619. doi:10.1016/0091-7435(85)90081-7 [PubMed] [Crosslink] Cited by: Kabat GC, Kim MY, Manson JE, et al. White Blood Cell Count and Total and Cause-Specific Mortality in the Women’s Health Initiative. Am J Epidemiol. 2017;186(1):63-72. doi:10.1093/aje/kww226 [PubMed] [PMC Full Text] [Crosslink]

  89. Pillai AA, Fazal S, Mukkamalla SKR, Babiker HM. Polycythemia. In: StatPearls. Treasure Island (FL): StatPearls Publishing; May 20, 2023. [PubMed]

  90. Lewandowska AM, Rudzki M, Rudzki S, Lewandowski T, Laskowska B. Environmental risk factors for cancer – review paper. Ann Agric Environ Med. 2019;26(1):1-7. doi:10.26444/aaem/94299 [PubMed] [Full Text]